Glenmark Life Sciences Limited IPO is going to hit the market on 27 July 2021 and closes on 29 July 2021. The company to raise ₹1513.60 crores (approx) via initial public offer with a face value of ₹2 per equity share.
Glenmark Life Sciences Limited IPO is going to hit the market in July 2021 and closes on July 2021. Glenmark Life Sciences Limited IPO open on Wednesday fixed a price band of Rs. a share for its Rs 1500 crore (approx) IPO. The face value of equity shares is ₹2. Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies. Check out Glenmark Life Sciences Limited IPO details.
How to apply Share Holder Quota in Glenmark Life Sciences Limited IPO:
If you want to apply Glenmark Life Sciences IPO in the share holder quota, you should buy at least 1 share of Glenmark Pharma. It should be in your demat account when the company announce their IPO date or before RHP.
Glenmark Life Sciences Limited IPO Date & Price Band:
| IPO Opening Date | Jul 27, 2021 |
| IPO Closing Date | Jul 29, 2021 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹2 per equity share |
| IPO Price | ₹695 to ₹720 per equity share |
| Market Lot | 20 Shares |
| Min Order Quantity | 20 Share |
| Listing At | BSE, NSE |
| Issue Size | [.] Eq Shares of ₹2 (aggregating up to ₹1513.60 Cr) |
| Offer for Sale | [.] Eq Shares of ₹2 (aggregating up to ₹453.60 Cr) |
Glenmark Life Sciences Limited IPO Tentative Timetable
The Glenmark Life Sciences Limited IPO open date is 27 Jul 2021 , and the close date is 29 Jul 2021. The issue may list on .
| IPO Open Date | Jul 27, 2021 |
| IPO Close Date | Jul 29, 2021 |
| Basis of Allotment Date | Aug 3, 2021 |
| Initiation of Refunds | Aug 4, 2021 |
| Credit of Shares to Demat Account | Aug 5, 2021 |
| IPO Listing Date | Aug 6, 2021 |
Glenmark Life Sciences Limited IPO Market Lot:
The Glenmark Life Sciences Limited IPO minimum market lot is 17 shares with ₹14,229 application amount. The retail investors can apply up-to 14 lots with 238 shares or ₹1,99,206 amount.
| Minimum Lot Size: | Minimum 20 Shares |
| Minimum Amount: | ₹14,400 |
| Maximum Lot Size: | Maximum 260 Shares |
| Maximum Amount: | ₹187,200 |
Glenmark Life Sciences Limited Company Financial:
| Particulars | For the year/period ended (₹ in million) | ||
|---|---|---|---|
| 31-Dec-20 | 31-Mar-20 | 31-Mar-19 | |
| Total Assets | 19,565.70 | 17,256.04 | 14,753.95 |
| Total Revenue | 14,184.72 | 15,493.03 | 8,868.65 |
| Profit After Tax | 2,468.97 | 3,130.98 | 1,955.92 |
Read Also:-
- Glenmark Life Sciences Limited IPO GMP (Grey Market Premium)
- Glenmark Life Sciences Limited IPO Subscription Status
- Glenmark Life Sciences Limited IPO Allotment Status
Glenmark Life Sciences Limited IPO Form:
How to apply the Glenmark Life Sciences Limited IPO? You can apply Glenmark Life Sciences Limited IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Clean Science and Technology IPO in the Invest section. The other option you can apply Glenmark Life Sciences Limited IPO via IPO forms download via NSE and BSE. Check out the Glenmark Life Sciences Limited IPO forms - click NSE Forms & BSE Forms blank IPO forms download, fill and submit in your bank or with your broker.
About Glenmark Life Sciences Limited
Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
Its products are being sold in India and also expoted to multiple countries i.e. Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.
Glenmark Life Sciences Limited IPO Prospectus
- Glenmark Life Sciences Limited DRHP
- Glenmark Life Sciences Limited RHP
Glenmark Life Sciences Limited Company Promoters:
- Glenmark Pharmaceuticals Limited
Glenmark Life Sciences Limited IPO Registrar:
KFin Technologies Private Limited (Formerly known as
Karvy Fintech Private Limited)
Selenium Tower-B
Plot No-31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500032
Telangana, India
Tel: +91 40 6716 2222
E-mail: glenmark.ipo@kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Website: www.kfintech.com
Contact Person: M Murali Krishna
SEBI Registration No.: INR000000221
Glenmark Life Sciences Limited IPO Lead Managers:
- Kotak Mahindra Capital Company Limited
- BofA Securities India Limited
- Goldman Sachs (India) Securities Private Limited
- DAM Capital Advisors Limited
- BOB Capital Markets Limited
- SBI Capital Markets Limited
Glenmark Life Sciences Limited Company Address:
Glenmark Life Sciences Limited
Registered Office:
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Maharashtra
Corporate Office:
Glenmark House, B. D. Sawant Marg,
Andheri (East), Mumbai 400099,
Maharashtra, India
Tel: +912189 234456/ +912189 234246
Website: www.glenmarklifesciences.com
Contact Person: Rudalf Corriea
(Company Secretary and Compliance Officer)
E-mail: complianceofficer@glenmarklifesciences.com
Glenmark Life Sciences Limited IPO FAQs
What is Glenmark Life Sciences Limited IPO?
Glenmark Life Sciences Limited IPO is a main-board IPO. They are going to raise ₹1513.60 Crores via IPO. The issue is priced at ₹695 to ₹720 per equity share. The IPO to be listed on BSE & NSE.
When Glenmark Life Sciences Limited IPO will open?
The Glenmark Life Sciences Limited IPO is to open on 27 July 2021 for QIB, NII, and Retail Investors.
What is Glenmark Life Sciences Limited IPO Investors Portion?
The investors' portion for Glenmark Life Sciences Limited ipo is QIB 50%, NII 15%, and Retail 35%.
How to Apply the Glenmark Life Sciences Limited IPO?
You can apply Glenmark Life Sciences Limited IPO via ASBA online via your bank account. You can also apply ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Glenmark Life Sciences Limited IPO through Zerodha?
Log in to Console in Zerodha Website. Go to Portfolio and Click on IPO. You will see the IPO Name "Glenmark Life Sciences Limited". Click on Bid Button. Enter your UPI ID, Quantity and Price. Submit IPO Application Form. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate.
What is Glenmark Life Sciences Limited IPO Size?
Glenmark Life Sciences Limited IPO size is ₹1513.60 crores (Approx).
What is Glenmark Life Sciences Limited IPO Price Band?
Glenmark Life Sciences Limited IPO Price Band is ₹695 to ₹720.
What is Glenmark Life Sciences Limited IPO Minimum and Maximum Lot Size?
The minimum bid is 20 Shares with ₹14,400 amount while maximum bid is 260 shares with ₹187,200.
What is Glenmark Life Sciences Limited IPO Allotment Date?
Glenmark Life Sciences Limited IPO allotment date is 03 Aug 2021.
What is Glenmark Life Sciences Limited IPO Listing Date?
Glenmark Life Sciences Limited IPO listing date is 06 Aug 2021. The IPO to list on BSE and NSE.
